AnalystsSilvan TurkcanSilvan Turkcan's Stock Forecasts
AnalystsSilvan Turkcan
Sectors:
Industries:
Analyst Ranking
Bottom 15%
#4540 out of 5327 analysts
Average Return
-1.86%
Win Rate
29%5 out of 17
Risk vs Reward
Poor
Good
Silvan Turkcan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Relay Therapeutics IncRLAY | +86.94% | $10.26 | $19.18 | 2026-03-17 - 2026-07-20 | Buy |
Relay Therapeutics IncRLAY | +47.31% | $13.02 | $19.18 | 2026-05-20 - 2026-07-20 | Buy |
Relay Therapeutics IncRLAY | +47.20% | $13.03 | $19.18 | 2026-04-28 - 2026-07-20 | Buy |
Exelixis IncEXEL | +5.03% | $52.87 | $55.53 | 2026-06-24 - 2026-07-20 | Buy |
Tuhura Biosciences IncHURA | +0.90% | $2.22 | $2.24 | 2026-04-27 - 2026-07-20 | Buy |
Silvan Turkcan Analyst Color
Get additional color on Silvan Turkcan's coverage of popular stocks
Silvan Turkcan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bandwidth IncBAND | 1 | Buy | $86.00 | +25.00% | Maintains | a day ago |
Faeth Therapeutics IncFTH | 1 | Buy | $51.00 | +80.92% | Initiates Coverage On | a day ago |
Celcuity IncCELC | 3 | Buy | $177.00 | +101.16% | Maintains | 6 days ago |
Crispr Therapeutics AgCRSP | 2 | Buy | $80.00 | +70.25% | Reiterates | 15 days ago |
Taysha Gene Therapies IncTSHA | 1 | Buy | $11.00 | +97.13% | Reiterates | 19 days ago |
Exelixis IncEXEL | 1 | Buy | $55.00 | -0.95% | Maintains | a month ago |
Intellia Therapeutics IncNTLA | 3 | Buy | $30.00 | +174.73% | Reiterates | a month ago |
Relay Therapeutics IncRLAY | 3 | Buy | $21.00 | +9.49% | Maintains | 2 months ago |
Tuhura Biosciences IncHURA | 1 | Buy | $9.00 | +301.79% | Initiates Coverage On | 3 months ago |
Cellectis SaCLLS | 1 | Buy | $8.00 | +207.69% | Reiterates | 3 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.